Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical company developing novel biologics.
I-Mab Biopharma has raised $220.0M across 1 funding round.
I-Mab Biopharma has raised $220.0M in total across 1 funding round.
I-Mab Biopharma has raised $220.0M in total across 1 funding round.
I-Mab Biopharma's investors include Hony Capital, Ally Bridge Group, C-Bridge Capital, CDH Investments, EDBI, Hillhouse Capital, HOPU Investments.
I-Mab Biopharma has raised $220.0M across 1 funding round. Most recently, it raised $220.0M Series C in June 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 29, 2018 | $220.0M Series C | Hony Capital | Ally Bridge Group, C-Bridge Capital, CDH Investments, EDBI, Hillhouse Capital, HOPU Investments |